Astoria, New York Clinical Trials

A listing of Astoria, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 550 clinical trials
Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

covid-19
SARS
acute respiratory distress
acute respiratory syndrome (sars)
respiratory distress
Holy Medical Center
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations
Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

This is a multicenter, open-label Phase 1 study of orally administered CB-5339 in participants with R/R AML or participants with R/R intermediate- to high-risk MDS.

bone marrow procedure
cervical cap
remission
glomerular filtration rate
refractory acute myeloid leukemia (aml)
Memorial Sloan Kettering Cancer Center
 (1.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

This study will find out whether people with CLL or SLL who have received treatment with venetoclax, either alone or in combination with another drug, and who are found to be MRD-negative, can stop treatment with venetoclax and remain off-treatment for 12 months or more. The researchers will also see …

lymphoma
formalin-fixed paraffin-embedded
monoclonal antibodies
remission
minimal residual disease
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (1.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

aortic valve replacement
fatigue
shortness of breath
regurgitation
New York-Presbyterian/ Columbia University Medical Center
 (4.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

testosterone
combined modality therapy
prostatic neoplasms, castration-resistant
enzalutamide
prostatic neoplasm
New York University, Langone Health
 (3.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +21 other locations
A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

The researchers are doing this study to find out whether the study drug hydroxychloroquine can prevent infection with the COVID-19 virus, compared with placebo, in people who are receiving radiation therapy for their cancer. The placebo used in this study is a tablet that looks the same as the study …

SARS
ache
breast cancer
dyspnea
diarrhea
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
 (1.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
Acne study trial

hello Acne study trial Hello!Acne study trial Hello!Acne study trial Hello!Acne study trial Hello!Acne study trial Hello!

New Site with only Phone
 (5.8 away) Contact site
  • 6 views
  • 04 Aug, 2023
  • 1 location
ctgov trial 2

    dddd

Test Site
 (3.2 away) Contact site
  • 0 views
  • 20 Aug, 2020
  • 1 location
Safety Pharmacokinetics and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Primary Objectives: Phase 1: To characterize the safety and tolerability of isatuximab in kidney transplant candidates. Phase 2: To evaluate the efficacy of isatuximab in desensitization of patients awaiting kidney transplantation. Secondary Objectives: Phase 2: To characterize the safety profile of isatuximab in kidney transplant candidates. To characterize the pharmacokinetic …

diphenhydramine
isatuximab
chronic kidney disease
kidney transplant
sar650984
Investigational Site Number 8400002
 (3.2 away) Contact site
  • 0 views
  • 12 Nov, 2020
  • +2 other locations
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

autologous hematopoietic stem cell transplant
daratumumab
lenalidomide
immunotherapeutic agent
ixazomib
Investigational Site Number 8400001
 (1.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +7 other locations